Atlas Trials

Evaluation of the Effect of a Daily Dose of Wakame Seaweed on Reducing Circulating Concentrations of Advanced Glycation End Products in Patients With Stage III Chronic Kidney Disease

Clinical trial NCT07729683 · RECRUITING

Trial details

NCT number
NCT07729683
Sponsor
Groupe Hospitalier de la Rochelle Ré Aunis
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Chronic Kidney Disease
Start date
2026-01-27
Primary completion
2027-10-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.